Professor Tim Dafforn was appointed as BEIS Chief Entrepreneurial Adviser in December 2016. Tim has extensive scientific and entrepreneurship experience. He was Entrepreneur in Residence at BIS from 2014-15 with a remit to champion the growth of the synthetic biology industry in the UK, he was also Chief Scientific Adviser for BIS from 2015-2016.
As BEIS’s Chief Entrepreneurial Adviser, a part-time role, he has responsibility for advising on Entrepreneurship Policy and championing and advising on all aspects of entrepreneurship relating to BEIS and the wider UK economy. Additionally, Tim is responsible for mobilising the UK’s Leading Entrepreneurs to inform policy making, mentor new business and develop a sophisticated, complimentary Market Intelligence Activity.
As Professor of Biotechnology at the University of Birmingham, Tim has established himself as a scientific multi-disciplinarian with more than 100 publications in Biology, Chemistry, Physics and Medicine and has secured £10 Million of grant funding. He has also developed a number of projects from inception through to commercial realisation including the formation of 2 spinout companies. Tim has also led academics in the delivery of research impact as Director of Knowledge Transfer for the College of Life and Environmental Sciences at the University.
Tim is currently leading a team of 12 scientists to research new methods to detect pathogens and infections and is developing a device that can be used by GPs to diagnose disease and recommend treatment. He is particularly interested in commercialising science for the common good. Tim has worked to develop new national research policies as part of the Biotechnology and Biological Sciences Research Council (BBSRC) New ways of working strategy panel, and the Synthetic Biology Leadership Council.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.